Firming booster

There are different effects tested depending on the dose used:

1. In vitro test: protection of the dermal matrix (collagen and elastin): reduction of MMP1 (-51%), cathepsin S (-34%) and stimulation of fibromodulin synthesis (+268%) and dermatopontin (+137%). Evaluation on human fibroblasts using wild ginger extract. Sederma 78612 Le Perray en Yvelines Cedex (France).
2. In vitro test: Reduction in fat storage: Inhibition of adipocyte maturation, the last stage in obtaining functional fat cells (-91%), and reduction of triglyceride storage (-29%). Modulating effect on the adipocyte of the inflammatory reaction generated by hypoxic conditions by supporting adiponectin secretion (+95%) and by reducing the rate of interleukin-6 (-73%). Assay of the active ingredient using wild ginger extract. Sederma 78612 Le Perray en Yvelines Cedex (France).
3. In vitro test: Antioxidant-antipollution effect by inhibiting reactive oxidation species (ROS) (-55%) and by increasing the synthesis of GSH, responsible for balancing the cells’ redox potential (67%) and the synthesis of ferritin, a protein complex whose role is to neutralise the highly oxidising free iron derived from the degradation of haemoglobin (+68%). Test on human fibroblasts and keratinocytes using wild ginger extract. Sederma 78612 Le Perray en Yvelines Cedex (France).
4. In Vivo Test: Improvement of leg heaviness (circulatory) (-24%). Test conducted with panellists on n=24 women and a test conducted by a phlebologist on n=27 volunteers; applying wild ginger extract 2 times/day; t=2 months, which confirmed the action of the active ingredient in improving leg heaviness and the overall beauty of the legs (thickness, veins, appearance). Sederma 78612 Le Perray en Yvelines Cedex (France).
5. In vitro test: Study on gene expression in mature human fibroblasts (+44% in 72h), analysing the expression of 9 genes related to the synthesis of collagen (I,V,VII,XVI), elastin (elastin, fibronectin and fibrillin-1) and hyaluronic acid (Hyaluronan synthase 2). Test of the active ingredient applying the epigenetic complex of liposomes with controlled release of maslinic acid. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
6. In vitro test: Growth in keratinocytes (+48% in 72h). Active test applying the epigenetic complex of liposomes with controlled release of maslinic acid. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
7. In vitro test: Leukocyte elastase inhibitor (-90%). Assay of the active ingredient using the epigenetic complex of liposomes with controlled release of maslinic acid. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
8. In Vitro Test: Antioxidant-antipollution (-80%) and increases cell vitality (+50%). Measured in human keratinocytes with the epigenetic complex of liposomes of controlled release of maslinic acid vs. placebo and comparison with vitamin C (which showed worse results with respect to our active ingredient). EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
9. In Vivo Test: Skin Thickness Index (+22%). Trial n=20 with ages between 30-55 years; applying the epigenetic complex of liposomes with controlled release of maslinic acid once a day in t=56 days. Measurement with cutometer -MPA 580 + clinical study. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
10. In Vivo Test: Skin hydration (+28%). Trial n=20 with ages between 30-55 years; applying the epigenetic complex of liposomes with controlled release of maslinic acid once a day in t=28 days. Measurement with cutometer -MPA 580 + clinical study. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
11. In Vivo Test: Skin elasticity (+20%). Trial n=20 with ages between 30-55 years; applying the epigenetic complex of liposomes of controlled release of maslinic acid once a day in t=56 days. Clinical study. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
12. In Vivo Trial: Anti-inflammatory (-90%). Trial n=20 with ages between 30-55 years; redness test applying the epigenetic complex of liposomes of controlled release of maslinic acid after t=60 minutes. Clinical study. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
13. In Vivo Test: Redensifies the skin (+210%). Trial n=20 with ages between 30-55 years; 1 use/day in t=56 days. Clinical study applying the epigenetic complex of liposomes with controlled release of maslinic acid. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.
14. In Vivo Test: Skin tonicity (+71%). Trial n=20 aged 30-55 years; applying the epigenetic complex of controlled-release liposomes of maslinic acid once a day for t=56 days. Clinical study. EG Active, Avda. Diagonal, 539 4º1º CP:08029 Barcelona.

• EFFECTIVENESS TESTS AT THE MAXIMUM DOSE OF USE (professional and public): 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14.

• EFFECTIVENESS TESTS AT REINFORCEMENT DOSE (professional only): 1, 2, 3, 5, 6, 7, 8..

DO NOT APPLY UNDILUTED TO THE SKIN.

Follow the instructions below to take the effective doses (syringe attached) and mix correctly.

A) Professional

1. Start or step 1:

Dispense into a 1000ml thalàxia anti-pollution normalising gel bowl, a total of 5 pulses (17.5ml).

2. Step 2:

Shake before use and take the effective dose (attached syringe) of 3ml of thalàxia anti-pollution firming booster to apply the maximum dose or 1ml as a booster dose to combine with another booster (consult the work protocols of the thalàxia body professional pack).

3. Step 3:

Add the dose from the syringe onto the thalàxia anti-pollution normalising gel and mix until completely homogeneous.

4. Step 4:

Apply the mixture to the area to be treated and apply the desired appliance* or work manually with a gentle massage in the direction of venous return in the legs, and in a circular motion on the buttocks, hips and belly, until no residue is left.

* It is possible to work with virtual mesotherapy (recommended), ionising in positive pole “+” and after the radio frequency.

5. Step 5:

It is recommended to finish the treatment with thalàxia anti-pollution normalising emulsion.

B) Public

1. Step 1:

Shake before use and take the effective dose (syringe attached) of 1ml of thalàxia anti-pollution firming booster.

2. Step 2:

Dispense a total of 5 pulses (6.2ml) of thalàxia anti-pollution normalising emulsion or normalising gel 200ml (as appropriate) into the hand or into a bowl.

3. Step 3:

Add the dose from the syringe onto thalàxia anti-pollution normalising emulsion or normalising gel and mix until completely homogeneous.

4. Step 4:

Apply the mixture to the area to be treated, with a gentle massage in the direction of venous return in the legs, and in a circular motion on the buttocks, hips and belly, until no residue is left.

Tips:

• Apply once or twice a day for at least 2 months.
• Before applying the treatment, it is advisable to exfoliate for better penetration of the product, and then (regularly) once a week.
• Apply the product after showering or bathing (the pores are more dilated and the active ingredients penetrate better).

Note: it is compatible with the following elinne cabin treatments as a final product:

• Thalàxia anti-pollution body treatment Meigetsuin ritual modelling, Hasedera ritual firming, Hokokuji ritual draining-circulatory and Jochiji ritual zen-thalassotherapy.

Formats

30ml bottle (PUBLIC and PROFESSIONAL).